Phase II study of panitumumab and paclitaxel as first-line treatment in recurrent or metastatic head and neck cancer. TTCC-2009-03/VECTITAX study
del Barco Morillo, Elvira, Mesía, Ricard, Adansa Klain, Juan Carlos, Vázquez Fernández, Silvia, Martínez-Galán, Joaquina, Pastor Borgoñon, Miguel, González-Rivas, Cyntia, Caballero Daroqui, Javier, Berrocal, Alfonso, Martínez-Trufero, Javier, Vera, Ruth, Cruz-Hernández, Juan Jesús
Published in Oral oncology (01.11.2016)
Published in Oral oncology (01.11.2016)
Get full text
Journal Article